Table 4.
Summary of the papers that examined cirrhotic, non-cirrhotic and various pre-cirrhotic stage occasion patients against each other. The arrows show (if applicable) whether a VOC level increased or decreased in the first group compared to the second group in the study design.
Author/Year | Study Design | Analytical Method | VOCs Identified as Significant | Discriminatory Performance |
---|---|---|---|---|
Alkhouri et al. 2015 |
20 advanced fibrosis vs. 41 mild fibrosis | SIFT-MS | Acetone ↓ Benzene ↓ Carbon disulphide ↓ Isoprene ↓ Pentane ↓ Ethane ↓ |
0.85 AUC (Isoprene model) |
Khalid et al. 2013 |
11 alcoholic cirrhotic with HE vs. 23 alcoholic cirrhotic without HE | GC-MS | Methyl-vinyl ketone ↓ Isothiocyanato-cyclohexane ↑ |
90% sensitivity 87% specificity |
34 alcoholic cirrhotic vs. 13 non-alcoholic cirrhotic | Undecane ↑ Unknown ↓ |
78.3% sensitivity 69.2% specificity |
||
34 alcoholic cirrhotic vs. 7 harmful drinkers | 1-methyl-4-(1-methyl-ethenyl)-benzene ↑ Unknown ↓ Unknown ↓ |
88% sensitivity 85% specificity |
||
7 harmful drinkers vs. 15 healthy | Octanal 2,6-dimethyl-7-octen-2-ol Unknown |
71% sensitivity 93% specificity |
||
13 non-alcoholic cirrhotic vs. 15 healthy | Methyl-vinyl ketone 1-methyl-2-(1-methyl-ethyl)-benzene (o-cymene) Unknown |
92% sensitivity 100% specificity |
||
34 alcoholic cirrhotic vs. 15 healthy | Heptane 1-methyl-2-(1-methyl-ethyl)-benzene Phellandrene 2-methyl-hexane |
97% sensitivity 93% specificity |
||
O’Hara et al. 2016 |
11 cirrhotic HE vs. 11 cirrhotic without HE vs. 7 history of HE vs. 30 healthy | PTR-MS | Limonene ↑ | Not reported |
10 without HCC vs. 21 HCC vs. 30 healthy | Limonene ↑ | Not reported | ||
Qin et al. 2010 |
30 HCC vs. 36 healthy | GC-MS-SPME | 3-hydroxy-2-butanone ↑ Styrene ↑ Decane ↑ |
83.3% sensitivity 91.7% specificity |
30 HCC vs. 27 cirrhotic without HCC | 3-hydroxy-2-butanone ↑ Styrene ↑ |
70% sensitivity 70.4% specificity |
||
Ferrandino et al. 2020 |
32 cirrhotic without HCC vs. 12 cirrhotic with HCC vs. 40 healthy controls | GC-MS | Limonene ↑ | 73% sensitivity 77% specificity |
Miller-Atkins et al. 2020 † only the three most significant metabolite associations for each disease comparison are shown in the column of significant compounds |
112 non-cirrhotic HCC vs. 54 healthy | SIFT-MS | (E)-2-nonene ↑ Ethane ↑ Benzene ↑ Hydrogen sulphide ↓ |
Healthy vs. all the rest 76% sensitivity 97% specificity |
30 cirrhotic without HCC vs. 54 healthy | Trimethyl-amine ↓ Propanol ↓ |
Cirrhotic vs. all the rest 40% sensitivity 96% specificity |
||
49 PH vs. 54 healthy | (E)-2-nonene ↑ Acetaldehyde ↑ Ethane ↑ Hydrogen sulphide ↓ |
HCC vs. all the rest 73% sensitivity 71% specificity |
||
51 CRLM vs. 54 healthy | (E)-2-nonene ↑ Acetaldehyde ↑ Triethyl-amine ↑ Acetone ↓ |
CRLM vs. all the rest 51% sensitivity 94% specificity |
||
112 non-cirrhotic HCC vs. 30 cirrhotic | Acetone ↓ Acetaldehyde ↓ Dimethyl-sulphide ↓ Ethanol ↑ |
PH vs. all the rest 58% sensitivity 93% specificity |
||
Arasaradnam et al. 2016 |
22 non-cirrhotic HE vs. 20 healthy | E-nose | Not available | 88% sensitivity 68% specificity |
13 covert non-cirrhotic HE vs. 9 overt non-cirrhotic HE | Not available | 79% sensitivity 50% specificity |
||
Solga et al. 2008 |
16 moderate to severe steatosis vs. 11 less steatosis | GC | Ethanol ↑ Acetone ↑ |
Not reported |
24 NASH vs. 24 without NASH | Acetone ↑ | Not reported | ||
Verdam et al. 2013 |
39 NASH vs. 26 without NASH | GC-MS | n-tridecane ↑ 3-methyl-butanonitrile ↑ 1-propanol ↑ |
90% sensitivity 69% specificity |
Alkhouri et al. 2013 |
37 obese NAFLD vs. 23 obese without NAFLD | SIFT-MS | Isoprene ↑ Acetone ↑ Trimethylamine ↑ Acetaldehyde ↑ Pentane ↑ |
0.76 AUC |
Millonig et al. 2010 |
37 cirrhotic vs. 35 healthy | IMR-MS | Ethanol ↑ | 0.88 AUC |
91 liver diseased vs. healthy | Acetaldehyde ↑ Ethanol ↑ Isoprene ↑ |
0.94 AUC | ||
34 NAFLD vs. healthy controls | Acetaldehyde ↑ | 0.96 AUC | ||
20 AFLD vs. 35 healthy | Acetaldehyde ↑ Isoprene ↑ |
0.97 AUC | ||
20 AFLD vs. 34 NAFLD | Isoprene ↑ | 0.95 AUC | ||
Letteron et al. 1993 |
89 alcohol abusers vs. 52 liver diseased vs. 42 healthy | GC-FID | Ethane ↑ | Not reported |
Hanouneh et al. 2014 |
80 liver diseased vs. 43 healthy | SIFT-MS | 2-propanol ↑ Acetaldehyde ↑ Acetone ↑ Ethanol ↑ Pentane ↑ Trimethylamine ↑ |
Not reported |
40 cirrhotic AH vs. 40 cirrhotic AD | Acetaldehyde ↑ Acetone ↑ Pentane ↑ Trimethylamine ↑ |
97% sensitivity 72% specificity (Acetone-pentane-trimethylamine) |